Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270395 · ClinicalTrials.gov registry record · NA
Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation
A NA study, sponsored by Laurie McLouth.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT05270395: Completed NA study, sponsored by Laurie McLouth.
NCT05270395 is a NA study that has completed, run by Laurie McLouth. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05270395, a NA study, has completed, sponsored by Laurie McLouth.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.
Primary Outcome
Enrollment feasibility is defined as the number of eligible and approached patients who agree to participate
Interventions
- BEHAVIORAL mPal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-07-28 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
What the finished NCT05270395 record still lists
NCT05270395 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which mPal is the first listed.
NCT05270395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05270395 about?
NCT05270395 is a clinical study titled "Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation". The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.
What is the current status of trial NCT05270395?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2022-07-28. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05270395?
The interventions under investigation include: mPal (BEHAVIORAL).
Who is sponsoring clinical trial NCT05270395?
This trial is sponsored by Laurie McLouth, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05270395's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI